コンテンツへスキップ
Merck

HCDC0001L0100

Mobius Gold High Cell Density Cryopreservation Assembly

(-196C), 100 mL, sterile; y-irradiated (at 25-40 kGy)

ログインで組織・契約価格をご覧ください。

サイズを選択してください

表示を変更する

この商品について

UNSPSC Code:
41103801
テクニカルサービス
お困りのことがあれば、経験豊富なテクニカルサービスチームがお客様をサポートします。
お手伝いします


Quality Segment

material

(flouropolymer), (thermoplastic elastomer), C-Flex® tubing (374), device, polypropylene , silicone (thermoplastic elastomer), tubing (Pharma 65)

agency

according to ISO 11137, meets EN 2.6.14, meets JP 4.01, meets USP 85

sterility

sterile; γ-irradiated (level of 25-40 kGy)

product line

Mobius®

packaging

package of 5 ×

parameter

-196- 60 °C temp. range (-321- 140 °F), 0.3 bar max. pressure (4.4 psi), 60 mL process volume

technique(s)

buffer exchange: suitable, media fill: suitable

capacity

100 mL

impurities

<0.25 EU/mL Aqueous extraction (LAL test)

fitting

plug (plug-end 1/8"HB), port (end-ported 2x 1/8"HB)

application(s)

cell therapy
gene therapy
life science and biopharma
liquid processing
mAb
ophthalmics
parenterals
pharma/biopharma processes
viral therapy
waste management

storage temp.

10-30°C

General description

Device configuration: 5 bags per assembly
Our Mobius® High Cell Density Cryopreservation (HCDC) Assembly (-196C) is a single-use assembly specially designed to facilitate the freeze and thaw of cryopreserved cells in liquid nitrogen vapor phase (? -196°C). Available in two assembly bag sizes of 100 mL and 250 mL, our Mobius® HCDC Assembly (-196C) enables seed train inoculation with cells at a higher cell density and larger volume compared to the traditional seed train process using vials, which significantly accelerates the cell expansion process. Our Mobius® single-use assembly also provides a closed processing environment preventing contamination while improving process reproducibility.

Application

Croyopreserved storage of cells

Biochem/physiol Actions

All component materials, in contact with sampling liquid, meet the criteria for Class VI testing based on USP <88> Biological Reactivity, in vivo.
Application

Features and Benefits

Standard products eliminate design and manufacturing lead times.Designed to facilitate the freeze and thaw of cryopreserved cells in liquid nitrogen vapor phase ( -196°C).

Packaging

Five (5) assembies per package with each assembly containing five (5) 100 mL cryo bags

Other Notes

Bags manufactured under ISO Clean Room Class 8 conditions in a facility certified to ISO 14644-1 standards. Assembly performed under ISO Clean Room Class 7 conditions in a facility certified to ISO 14644-1 standards.
Fluoropolymer bags: Tubing: Silicone and Thermoplastic ElastomerFittings: PolypropyleneNovaSeal Pinch Pipes: Nickel plated brass
Pinch clamp: Nylon

Legal Information

C-Flex is a registered trademark of Saint-Gobain Performance Plastics Corp.
MOBIUS is a registered trademark of Merck KGaA, Darmstadt, Germany


Still not finding the right product?




Emprove®プログラムを使用してGMPを遵守します。

Emprove® Dossiersで資格認定を加速し、コンプライアンスを維持し、時間を節約しましょう。

Dossiers をダウンロード

注意: EmproveSuite.comに移動します。ユーザー名とパスワードはSigmaAldrich.comとは別のもので、異なる場合があります

無料会員登録すると、数分でEmprove® Dossiersにアクセスできます。 購読プランをアップグレードして、Emprove® Suiteの高度でカスタマイズされたコンテンツをアンロックしてください。

お探しのものが見つかりませんか?Emprove® プログラムのヘルプページをご覧ください。.

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする


資料

How the Cellicon® filter and controller enables seamless adoption of a perfused N-1 seed train step into the cell expansion process.

High cell density cryopreservation (HCDC) is a closed processing alternative to the traditional seed train expansion process. Learn more about the benefits of HCDC.

Cellvento 4CHO-X Expansion Medium enhances cell biomass for bioreactor inoculation in cell expansion stages.

すべての記事を見る

関連コンテンツ

バイオ医薬品の開発業者は、高品質のモノクローナル抗体(mAb)などのさまざまなタイプの組換えタンパク質を供給する効率的で生産性の高いアップストリームプロセスを必要としています。プロセスの強化は、将来も有効な製造戦略を採用して、コストを削減し、製造施設の柔軟性を高めることができます。

Biopharmaceutical developers need efficient, productive upstream processes that deliver high quality monoclonal antibodies (mAbs) and other types of recombinant proteins. Process intensification can future-proof their manufacturing strategies, reduce costs, and increase facility flexibility.

すべての関連コンテンツを見る